DYN
Dyne Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$24.28
−2.69%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-74.0%
Return on equity
-52.3%
Return on assets
-74.4%
Return on invested capital
0.00x
Asset turnover
-$477.8M
Cash from operations
$4.81
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026